Australia and New Zealand Melanoma Trials Group Revenue and Competitors

AU

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • Australia and New Zealand Melanoma Trials Group's estimated annual revenue is currently $16M per year.(i)
  • Australia and New Zealand Melanoma Trials Group's estimated revenue per employee is $112,200

Employee Data

  • Australia and New Zealand Melanoma Trials Group has 143 Employees.(i)

Australia and New Zealand Melanoma Trials Group's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.2M19N/AN/AN/A
#2
$16M143N/AN/AN/A
#3
$8.5M83-1%N/AN/A
#4
$9.4M9218%N/AN/A
#5
$7.9M778%N/AN/A
#6
$11M10816%N/AN/A
#7
$9.4M9210%N/AN/A
#8
$15.8M1417%N/AN/A
#9
$16M1437%N/AN/A
#10
$25.5M22721%N/AN/A
Add Company

What Is Australia and New Zealand Melanoma Trials Group?

The Australia and New Zealand Melanoma Trials Group (ANZMTG) coordinates and conducts quality research for melanoma control. We develop and undertake melanoma studies in collaboration with researchers and health care professionals, support networks and consumers.

keywords:N/A

N/A

Total Funding

143

Number of Employees

$16M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Australia and New Zealand Melanoma Trials Group News

2022-04-06 - IRC Determines BRUKINSA® (Zanubrutinib) Demonstrates ...

... 652 patients were enrolled in the ALPINE trial across Europe (60%), the United States (17%), China (14%), New Zealand and Australia (9%)...

2022-04-06 - Fierce Biotech Layoff Tracker: Layoffs hit small biotechs Finch ...

Zealand Pharma: After a new drug launch went sideways, Zealand had to reduce ... 2 trial and terminated an agreement with the COPD Foundation in January.

2022-04-06 - The top 20 pharma companies by 2021 revenue

Bristol is hoping to fill that gap with a group of new launches. ... emerging markets, plus Japan, Australia, New Zealand and greater China.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$23.6M14310%N/A
#2
$20.4M14327%N/A
#3
$31.8M143N/AN/A
#4
$38.5M1437%N/A
#5
$15.7M1436%N/A